Petitclerc E - Search Results

1

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis.

McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC, Lawrence DA. McMahon GA, et al. Among authors: petitclerc e. J Biol Chem. 2001 Sep 7;276(36):33964-8. doi: 10.1074/jbc.M105980200. Epub 2001 Jul 5. J Biol Chem. 2001. PMID: 11441025 Free article.

2

Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1.

Stefansson S, Petitclerc E, Wong MK, McMahon GA, Brooks PC, Lawrence DA. Stefansson S, et al. Among authors: petitclerc e. J Biol Chem. 2001 Mar 16;276(11):8135-41. doi: 10.1074/jbc.M007609200. Epub 2000 Nov 16. J Biol Chem. 2001. PMID: 11083866 Free article.

3

Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling.

Stefansson S, McMahon GA, Petitclerc E, Lawrence DA. Stefansson S, et al. Among authors: petitclerc e. Curr Pharm Des. 2003;9(19):1545-64. doi: 10.2174/1381612033454621. Curr Pharm Des. 2003. PMID: 12871067 Review.

4

New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.

Petitclerc E, Boutaud A, Prestayko A, Xu J, Sado Y, Ninomiya Y, Sarras MP Jr, Hudson BG, Brooks PC. Petitclerc E, et al. J Biol Chem. 2000 Mar 17;275(11):8051-61. doi: 10.1074/jbc.275.11.8051. J Biol Chem. 2000. PMID: 10713126 Free article.

5

Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.

Petitclerc E, Strömblad S, von Schalscha TL, Mitjans F, Piulats J, Montgomery AM, Cheresh DA, Brooks PC. Petitclerc E, et al. Cancer Res. 1999 Jun 1;59(11):2724-30. Cancer Res. 1999. PMID: 10363998

6

The chimeric human/mouse model of angiogenesis.

Petitclerc E, von Schalscha T, Brooks PC. Petitclerc E, et al. Methods Mol Biol. 2000;137:213-21. doi: 10.1385/1-59259-066-7:213. Methods Mol Biol. 2000. PMID: 10948540 No abstract available.

7

Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo.

Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS, Davis GE, Brooks PC. Xu J, et al. Among authors: petitclerc e. J Cell Biol. 2001 Sep 3;154(5):1069-79. doi: 10.1083/jcb.200103111. J Cell Biol. 2001. PMID: 11535623 Free PMC article.

8

The chick embryo metastasis model.

Petitclerc E, Brooks PC. Petitclerc E, et al. Methods Mol Med. 2001;58:173-87. doi: 10.1385/1-59259-137-X:173. Methods Mol Med. 2001. PMID: 21340857

9

Effect of reproductive hormones on ovarian epithelial tumors: II. Effect on angiogenic activity.

Chen C, Petitclerc E, Zhou H, Brooks PC, Sun T, Yu MC, Zheng W, Dubeau L. Chen C, et al. Among authors: petitclerc e. Cancer Biol Ther. 2002 May-Jun;1(3):307-12. doi: 10.4161/cbt.87. Cancer Biol Ther. 2002. PMID: 12432284

10

Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance.

Petitclerc E, Deschesnes RG, Côté MF, Marquis C, Janvier R, Lacroix J, Miot-Noirault E, Legault J, Mounetou E, Madelmont JC, C -Gaudreault R. Petitclerc E, et al. Cancer Res. 2004 Jul 1;64(13):4654-63. doi: 10.1158/0008-5472.CAN-03-3715. Cancer Res. 2004. PMID: 15231678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page